Healthy Skepticism Library item: 5159
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Salerno RA, Lesko LJ.
Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
Pharmacogenomics J 2006 Mar-Apr 01; 6:(2):78-81
http://www.nature.com/tpj/journal/v6/n2/abs/6500345a.html
Keywords:
Drug Design*
Drug Industry*/standards
Drug Industry*/trends
Genetic Markers
Pharmacogenetics*/standards
Pharmacogenetics*/trends
Risk Assessment
United States
United States Food and Drug Administration
